Abstract 104P
Background
We evaluated the feasibility of functional magnetic resonance (MR) signature in predicting clinical response to chemotherapy in colorectal liver metastatic (CLM) patients.
Methods
From August 2016 to January 2023, eligible CLM patients were enrolled and functional MR was performed at baseline and one cycle after chemotherapy. The diffusion kurtosis radiomic texture features were extracted and functional MR-imaging signature model was built by the R package called “glmnet” to predict the efficacy of treatment. The initial 100 cases were utilized as training set, the following 48 cases as validation set, and the latter 48 cases as intervention validation set. The primary endpoint was the accuracy of MR-predicted response (ORR) of liver metastases.
Results
The functional MR signature was established and showed a good performance of response prediction (AUC was 0.818 in training cohort and 0.755 in validation cohort). In training set, ORRs were 9.5% (4/42) and 72.4% (42/58) in high-risk and low-risk subgroups. In validation set, the ORRs were 23.81% (5/21) and 74.07% (20/27) in high-risk and low-risk subgroups, respectively (P=0.002). Worse PFS and OS were observed in high-risk population in these two sets. In intervention set, chemotherapy regimen was changed in 22.9% (11/48) patients who were predicted as high-risk by the model, and the ORR reached 54.6 % (6/11), which was higher than that in high-risk subgroups in training and validation set.
Conclusions
Functional MR signature effectively predicts chemotherapy response and long-term survival of patients with CLM, and regimen adjustment guided by the model significantly improve the ORR.
Clinical trial identification
NCT03088163.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
321P - Epidemiology and survival analysis of epithelial ovarian cancer: Results from comprehensive care center in north India
Presenter: Amit Badola
Session: Poster Display
Resources:
Abstract
322P - Evaluation of chemotherapy response score as a prognostic factor in advanced epithelial ovarian cancer: A prospective single centre study
Presenter: Upasana Palo
Session: Poster Display
Resources:
Abstract
323P - Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio as prognostic biomarkers in ovarian cancer among the Asian population: A meta-analysis
Presenter: Wikania Wira Wiguna I Gede
Session: Poster Display
Resources:
Abstract
324P - All-<italic>trans</italic> retinoic acid sensitizes ovarian cancer to niraparib by inhibiting ALDH1A1 activity
Presenter: Bingjie Mei
Session: Poster Display
Resources:
Abstract
325TiP - A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04)
Presenter: Myong Cheol Lim
Session: Poster Display
Resources:
Abstract
327TiP - A single arm phase II study of single agent pemetrexed in platinum resistant/refractory epithelial ovarian or primary peritoneal cancer
Presenter: Swasthik Parampalli
Session: Poster Display
Resources:
Abstract
337P - Demographic patterns and survival outcomes of patients with T and NK-cell lymphoma at the National Cancer Centre Singapore
Presenter: Mohamed Haniffa Bin Hasan Mohamed
Session: Poster Display
Resources:
Abstract
338P - Multicenter real-world study of advanced-stage non-nasal type NK/T cell lymphoma (NKTCL): Clinical features, treatment and prognosis
Presenter: Yuce Wei
Session: Poster Display
Resources:
Abstract
339P - A comparison of survival of patients with relapsed or refractory diffuse large B cell lymphoma undergoing allogeneic stem cell transplantation or receiving CAR-T therapy
Presenter: Kenta Hayashino
Session: Poster Display
Resources:
Abstract
340P - The role of CT scans and laboratory tests for surveillance in patients with diffuse large B cell lymphoma who achieved complete remission after first-line chemotherapy
Presenter: YU Yagi
Session: Poster Display
Resources:
Abstract